chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe vertigo after 2nd shot. Approx 18 after second dose. Vomiting and spinning. Lasted severe for 12 hours. Intermittent vertigo daily since 4-5 times but not enough to throw up. Night 5 severe vertigo throwing up. Lasted 4 hours.
COVID symptoms; cold; low grade fever of 99 something; headache; falling asleep; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), SOMNOLENCE (falling asleep), FATIGUE (exhausted) and PYREXIA (low grade fever of 99 something) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Uknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced SOMNOLENCE (falling asleep) and FATIGUE (exhausted). On 16-Feb-2021, the patient experienced SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), PYREXIA (low grade fever of 99 something) and HEADACHE (headache). On 17-Feb-2021, SUSPECTED COVID-19 (COVID symptoms), NASOPHARYNGITIS (cold), SOMNOLENCE (falling asleep), FATIGUE (exhausted), PYREXIA (low grade fever of 99 something) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
According to Pt's daughter-in-law, pt felt weak, exhausted, mentally confuse and lost weight.
Diagnosed with a dvt blood clot in my left leg on 04/02/2021. On eliquis and warfarin.
Injection was given 12/8/2008. Patient notified pharmacy 12/22 at 9:40 am. Full body rash. Called Dr. Dr told her to take ZYRTEC and ZANTAC OTC.
Information has been received from a physician for the Pregnancy Registry of GARDASIL concerning a 16 year old female who on 07-FEB-2008 was vaccinated  with her first dose of GARDASIL (lot # not reported).  Concomitant therapy included a dose of VARIVAX (lot number unknown).  Other concomitant therapy included MENACTRA.  On 19-FEB-2008 the patient had a positive pregnancy test.  Her LMP was 25-JAN-2008.  Follow-up information was received from the physician.  The patient had medical history of depression.  Concomitant medication during her pregnancy included KEFLEX for UTI (started on 11-JUN-2008) and ZITHROMAX for bronchiolitis (started on 08-SEP-2008).  On 29-OCT-2008, the patient delivered a normal, health male baby (no congenital anomalies), weighing 7 pounds 14 ounces, 20 inch in length, with Apgar score 9/9 and head circumference 50.5 cm.  There were no complication during labor or delivery.  Additional information is not expected.
patient took a flu shot every year until she was 37 and had the flu numerous times each year; Initial information regarding an unsolicited valid non-serious case was received from a consumer (patients husband) via Social Media and transmitted to Sanofi on 11-Nov-2020.   This case involves an adult female patient who took a flu shot every year until she was 37 and had the flu numerous times each year (Influenza), while she received vaccine INFLUENZA VACCINE.  Medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.  On an unknown date, the patient took INFLUENZA VACCINE (produced by unknown manufacturer) (lot number: unknown, via an unknown route in an unknown administration site prophylactic vaccination) every year until she was 37 years old and had the flu numerous times each year (influenza). The reporter and his wife (patient) received the INFLUENZA VACCINE and the reporter suggested that the patient should skip the INFLUENZA VACCINE and she never took INFLUENZA VACCINE again and did not experience influenza again.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as unknown for influenza.  There will be no information regarding the batch number for the case.
pt became faint, pale & had mild SOB w/in 1-2hr of being vaccinated;pt seen in ER & ER MD felt rxn was d/t vax;pt observed in ER x 60min;
This spontaneous report as received from an other refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL 9 lot # N001533 for prophylaxis. Other suspect therapies included PEDVAXHIB lot # M014925. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to GARDASIL 9.
Child started high pitched screaming about 3 hrs after received DTP continued for 4 hrs. Stated that had fever but doesn't know how high it was says that leg is real swollen & discolored at inject site.
Weakness in the arm; Pain in the arm; legs feel weak; aches and pains; the skin in her forearm feels funny; general weakness, a little bit tired; general weakness, a little bit tired; tenderness when she presses on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness in the arm), PAIN IN EXTREMITY (Pain in the arm), MUSCULAR WEAKNESS (legs feel weak), PAIN (aches and pains) and SENSORY DISTURBANCE (the skin in her forearm feels funny) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced MUSCULAR WEAKNESS (Weakness in the arm), PAIN IN EXTREMITY (Pain in the arm), MUSCULAR WEAKNESS (legs feel weak), PAIN (aches and pains), ASTHENIA (general weakness, a little bit tired), FATIGUE (general weakness, a little bit tired) and VACCINATION SITE PAIN (tenderness when she presses on the injection site). 25-Feb-2021, the patient experienced SENSORY DISTURBANCE (the skin in her forearm feels funny). At the time of the report, MUSCULAR WEAKNESS (Weakness in the arm), PAIN IN EXTREMITY (Pain in the arm), MUSCULAR WEAKNESS (legs feel weak), PAIN (aches and pains), SENSORY DISTURBANCE (the skin in her forearm feels funny), ASTHENIA (general weakness, a little bit tired), FATIGUE (general weakness, a little bit tired) and VACCINATION SITE PAIN (tenderness when she presses on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided. CONCOMITANT INFORMATION WERE NOT PROVIDED.
Since taking shot, patient has experienced chills. Patient took temperature morning after shot, at 1:15 pm, and 99.1 degree F, chills resolved 9/10/19 Wed night.
Information has been received from a health professional concerning a patient who was vaccinated with a 2ml oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine). Subsequently the patient vomited. It noted that the dose was not repeated. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a health professional indicated that the patient gagged a little but swallowed the dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live.  There was no vomiting.  Additional information is not expected.
Monovalent vaccine was administered as booster dose after bivalent EUA. There was not clear knowledge that monovalent could no  longer be administered as booster dose or that it was no longer authorized for booster dose.   The following 84 patients received monovalent vaccine as booster dose after 8/31.
Pt reports fever of 102, nausea within 12 hours of receiving vaccine. Advised to take acetominophen, enc cl liqs, bland foods
Started about 5-6 hours post vaccine with tiredness, low grade fever, chills, and pains and it escalated in the following hours and continued through the night. Currently (36 hours after the vaccine) have painful swelling and lump under armpit, fever 102.3, sever chills, aches, joint pain, moderate headache and stomach ache, lost weight 3lb in less than 24 hours, even though had a lot of hydration.
Horrible headache, Fever (102), skin burning, nausea, dizziness, weakness.   Around 1:00 am, I woke with a burning fever; checked temp throughout the night and it reached 102 around 4:00am.  Extreme dizziness caused me to fall returning to bed from bathroom. Fever broke around 7:am.  Called PCP around 8:30.  He advised tylenol and rest. Headache still present on 3/4; dizziness prevails.  Periodic nausea and fatigue still present.  I tested positive for COVID on 12/07/2020.   I AM AFRAID TO RECEIVE THE SECOND DOSE.  What happens if I don't?
Patient said she got an infection from the vaccines given to her. The FLUZONE and PREVNAR.
5-11yo orange cap version given to 14 year old. No adverse effect. We will give purple cap dose for 2nd dose per CDC recommendation.
I experienced that Shingles about 6 years go/I dealt with this shingles for a few days; It was unbearably painful/it was very uncomfortable and excruciating pain; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were recovered/resolved.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR123678   Additional Information: GSK receipt date: 22-AUG-2022 Reporters comment: This case was reported by a patient via interactive digital media. The patient received first dose of shingle vaccine 6 years ago and experienced pain and shingles. The patient also sated that shingles was for few days and it was very uncomfortable and excruciating pain. The patient thought initially not going to recovered but that was recovered. Additional Supportive information: For tolerance of 2nd dose of Shingles vaccine, refer case US2022AMR123678.; Sender's Comments:  US-GSK-US2022AMR123678:Same reporter
After my shot I had very tender lymph nodes on my L breast or under my arm. And then swelling of the lymph nodes and then I was concerned that I had more nodules in my breast that I had already removed. So I went to see Dr. and she felt that it was from the vaccine that caused the swelling of the lymph nodes and suggested that I wait 8 weeks to get a mammogram and an ultrasound. And I will be doing those for a follow up at the end of the month (October).
The patient is under the age of 18 years old and received the bi-valent version of Moderna. After speaking with the mother the patient has not shown any signs of adverse effects or symptoms.
101. Fever, chills, body aches , fatigue, malaise, swollen tenderness lymph node lt armpit.
This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program A male patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included ongoing eczema. Concomitant medications were not reported. The patient previously took dupilumab (DUPIXENT) for eczema. The patient experienced flare up of eczema on an unspecified date. Clinical outcome the event was unknown.    Information about lot/batch number has been requested.
Vaccine was administered correctly and per protocol/prescription.  Patient said she had itchiness, redness and the area was warm and sore from Sunday.  Patient unable to state whether has gotten worse over past 2 days but concerned it's cellulitis.  Pharmacist suggested she mark perimeter of rash and if worse tomorrow see clinician.
Tinnitus, primarily in the left ear, increasing in frequency since late December/early January to current status, which is daily
pt in the evening after receiving the shingrix shot started having severe pain in arm and rash on chest and arm.
Approximately 2 months after my booster I experienced the following: Initially I felt light headed and nauseous for about 90 seconds then I lost consciousness. I was brought to the ER and they did some blood work and EG and all the tests were normal. They sent me home and I had to follow up with my primary care and he ordered a D-Dimer test which turned out positive and I did a CAT Scan and it showed that I had 2 blood clots in my lung. I was prescribed with Eliquis and since then I have no episodes of losing consciousness.
Injection site red and sore with nominal swelling 12 hours after injection. 8 days later injection site swollen, hard, red, rash and itchy about the size of a extra large egg.  This is the first vaccine received in more than 30 years, as I had Guillian Barre Syndrome at the age of 8.
Sore Arm, doesn't hurt, just sore; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: unknown), via an unspecified route of administration on an unspecified date (at an unspecified age) at single dose for COVID-19 immunization. The patient medical history included ongoing blood disorder. The patient's concomitant medication included ongoing warfarin as a blood thinner before her first dose. The patient experienced sore arm, doesn't hurt, just sore on an unspecified date. The outcome of the event was unknown. Patient wanted to be sure that it was okay that she was on blood thinner and can take second dose.  No follow-up attempts are possible, information about batch/lot number cannot be obtained.
Pre-medicated with Benadryl 50 mg PO. Flushed/anxious. BP 184/101, pulse 82, O2 sat 100%.
My 14 month old was given the full adult dose Pfizer covid shot instead of her third lower dose.
Client received the COVID vaccine (Moderna, 1st dose,  lot #041AB21A, exp. 5/6/2021) at 1527. EMT observed the client to be pale and diaphoretic; he and RN responded at 1532. The client complained of dizziness, feeling clammy, and ringing in his ears, as well as spotty vision. His vital signs were as follows: blood pressure 96/78, heart rate 50, respiratory rate 20, and O2 99%. The client stated that he has hypertension and he takes losartan. He takes no other medications, has no other medical conditions, and has no allergies that he is aware of. The client was alert and oriented, and his pupils were equal and reactive to light. He stated that he ate breakfast and a snack at 11 am, but nothing for lunch. The client was offered water. At 1536, the client complained of tingling in his arms and numbness in his tongue. His color had returned to normal. No difficulty breathing, no swelling observed around his mouth or tongue, no complaint of metallic taste. Repeat vital signs were as follows: blood pressure 110/80, heart rate 87, O2 99%. He refused benadryl. At 1541, the client stated that his tongue was no longer numb but his arms were still tingling. He was less diaphoretic. His vital signs were as follows: blood pressure of 116/82, heart rate of 92, respiratory rate 14, and O2 97%. At 1545, the client stated he was no longer dizzy and his symptoms had resolved. Education provided regarding, emergency response and AMR activation, and primary care follow up. At 1550, the client was able to stand up and walk without any dizziness or feeling lightheaded. At 1558, the client's repeat vital signs were as follows: blood pressure 140/99, heart rate 99, respiratory rate 16, and O2 97%. The client was escorted outside by the EMT, and stated he was walking across the parking lot to get some food to eat before returning home. The client left the facility ambulating with a steady gate.
Primarily a local reaction with erythema & edema & mild fatigue afebrile.
I contacted her grandmother on 02/11/2010 to schedule her second vaccination.  At that time she stated that she took her to the ED after she had vomiting and diarrhea for one week after the intranasal spray.  She stated the ED told her she had a reaction to the H1N1 spray.
Narrative:  72 yo M with PMH of HLD, HTN and CAD h/o NSTEMI 4/2/2020 at hospital (outside facility) found to have 3 vessel CAD and he was transferred to hospital (outside facility) where he underwent CABG Coronary artery bypass graft x 5. On 6/22/2021 pt arrived at hospital ER unconscious after diagnosed with cardiac arrest. Pt died same day, on 6/22/2021. Pt had received covid vaccines on 2/23/2021 and on 3/23/2021. It appears death is not related to vaccinations.
COVID pneumonia, Covid 19 positive, acute respiratory failure, hypoxia; Encephalopathy; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 PNEUMONIA (COVID pneumonia, Covid 19 positive, acute respiratory failure, hypoxia) and ENCEPHALOPATHY (Encephalopathy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Chronic migraine, Fibromyalgia, DVT, Pulmonary embolism, Clotting disorder, Bipolar disorder, Immunodeficiency, Chronic obstructive pulmonary disease, Congestive heart failure, Hypertension, Arthritis, Drug allergy (Allergy to cephalosporins, NSAIDS, Quinolones, Darvocet, trazodone, lyrica), Peanut allergy (Allergy to peanut, tree nut) and Latex allergy. Concomitant products included ALBUTEROL [SALBUTAMOL], AMLODIPINE, BUSPIRONE, CILOSTAZOL and CYCLOBENZAPRINE for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced COVID-19 PNEUMONIA (COVID pneumonia, Covid 19 positive, acute respiratory failure, hypoxia) (seriousness criteria hospitalization and medically significant) and ENCEPHALOPATHY (Encephalopathy) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on 28-Mar-2021 due to COVID-19 PNEUMONIA and ENCEPHALOPATHY. At the time of the report, COVID-19 PNEUMONIA (COVID pneumonia, Covid 19 positive, acute respiratory failure, hypoxia) and ENCEPHALOPATHY (Encephalopathy) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Chest X-ray: Multifocal pneumonia. In March 2021, Computerised tomogram: CT head showed Punctate hyper density in the right hemipons without direct correlation on previous imaging. In March 2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment medications were provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, COVID19 pneumonia  a causal relationship may be unlikely related. Encephalopathy may ensue with the widespread infection stemming from COVID19.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, COVID19 pneumonia  a causal relationship may be unlikely related. Encephalopathy may ensue with the widespread infection stemming from COVID19.
02/11/2021 Noon - severe nausea 2200 - nausea resolved 2330 - extreme fatigue which continued through 03/06/2021 then became moderate fatigue - continues to present. 02/12/2021 0030 - dry raspy cough - continues to present but lessened in intensity over time.  HISTORY 01/2020 01/08/2020 - felt fine at movie theater, while walking to car swallowed & became aware that my throat was suddenly quite sore - difficult to swallow. Within 15min throat so sore could hardly swallow. Had start of dry cough.  ON increased dry cough; HA; joint pain; sweats/chills; low grade fever. 01/10/2020 - HA resolved. Sore throat less painful; very uncomfortable dry cough. Extreme fatigue. 01/11-19/2020 - Due to fatigue, unable to be out of bed for more than a few minutes. Hydrating/soup. Couldn't carry on verbal conversation due to dry cough - no SOB if didn't try to talk. 01/20/2020 - Was able to get up & dressed; left house for short time. Felt better, cough less of problem but persisted. Took about 3-4 weeks to feel 100%.  AN ASIDE My osteoarthritis pain, in left hip only, began to get much worse after 01/2020 episode. It took a quantum leap forward in pain again after 1st COVID-19 vaccination.
This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of malaise (didn't feel well this weekend) and influenza (twice tested positive for type A flu) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 003A21A) for COVID-19 immunization. No medical history reported. On Mar 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 24, 2021, patient experienced influenza (twice tested positive for type A flu). On an unknown date, patient experienced malaise (didn't feel well this weekend). The patient treated with Z-Pak (azithromycin), at an unspecified dose and frequency. At the time of the report, malaise (didn't feel well this weekend) and influenza (twice tested positive for type A flu) outcome: unknown/not provided. Diagnostic results: On Mar 24, 2021, influenza A virus test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications provided. Most recent follow-up information incorporated: On May 20, 2021: Additional information received on May 20, 2021 contained no new information.
Pt had MMRV and Kinrix  in left leg.  Several hours later her parents reported severe pain, redness, and swelling of leg.  They called telephone triage line and were told to use ice packs and ibuprofen.  They did and site improved overnight.  No fevers, no ongoing problems at this time.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. The patient injured his foot while mowing the lawn on an unspecified date about a month ago on September 2013. On 08-OCT-2013, after that injury the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiry not reported). On an unknown date in October 2013, the patient was recently prescribed prednisone (manufacturer unknown) for the unspecified foot injury and will begin taking it on an unspecified date in the future. Patient sought medical attention. The pharmacist stated she was busy and disconnected abruptly. The outcome of foot injury was unknown. Additional information has been requested.
This spontaneous report as received from nurse practitioner refers to a patient of unknown age and gender. No medical history and concurrent conditions reported. On 19-JUN-2015, the patient was inadvertently administered with improperly stored MMR II vaccine, lot # K002816, expire date: 25-FEB-2016 (dose, route, therapy type not reported). No adverse effects reported. No product quality complaint reported. Additional information has been requested.